| Pharmacotherapeutic treatment options for recurrent epithelial ovarian cancer | | |
| Ovarian Germ Cell Tumors: Pictorial Essay | | 2022 |
| Primary high-grade serous cancer arising from uterosacral ligament endometriosis: two case reports | Journal of International Medical Research | 2022 |
| Platinum vs non-platinum chemotherapy for platinum-resistant ovarian cancer: a systematic review and meta-analysis | | |
| Nonepithelial ovarian cancer – the current clinical practice in the Nordic countries. Survey from the surgical subcommittee of the Nordic society of gynecological oncology (NSGO) | Acta Oncológica | |
| Systematic lymph node dissection during interval debulking surgery for advanced epithelial ovarian cancer: a systematic review and meta-analysis | Journal of Gynecologic Oncology | |
| Formulation of an ovarian cancer vaccine with the squalene-based AddaVax adjuvant inhibits the growth of murine epithelial ovarian carcinomas | Clinical and Experimental Vaccine Research | 2022 |
| PET-CT in Clinical Adult Oncology—IV. Gynecologic and Genitourinary Malignancies | Cancers | 2022 |
| A Pan-Canadian Consensus Statement on First-Line PARP Inhibitor Maintenance for Advanced, High-Grade Serous and Endometrioid Tubal, Ovarian, and Primary Peritoneal Cancers | Current Oncology | 2022 |
| Multiple isolated ovarian cancer recurrences in the cervix and vagina after supracervical hysterectomy: A case report | Gynecologic Oncology Reports | 2022 |
| Impact of neoadjuvant chemotherapy on somatic mutation status in high-grade serous ovarian carcinoma. | Journal of Ovarian Research | 2022 |
| The roles and limitations of bevacizumab in the treatment of ovarian cancer. | International Journal of Clinical Oncology | 2022 |
| Different Surgical Approaches for Early-Stage Ovarian Cancer Staging. A Large Monocentric Experience. | Frontiers in Medicine | 2022 |
| Table_1.DOC | | 2020 |
| Single-Institution Retrospective Analysis of Ovarian Cancer Outcomes from the Middle Eastern Republic of Georgia | Indian Journal of Gynecologic Oncology | 2022 |
| Efficacy of non‑platinum chemotherapy in platinum‑resistant ovarian cancer: a meta‑analysis | Malignant Tumours | 2022 |
| Ovarian cancer recurrence detection may not require in-person physical examination: an MSK team ovary study. | International Journal of Gynecological Cancer | 2021 |
| Survival and reproductive outcomes after fertility-sparing surgery performed for borderline epithelial ovarian tumor in Japanese adolescents and young adults: Results of a retrospective nationwide study. | Journal of Obstetrics and Gynaecology Research | 2021 |
| Trends in the Incidence and Survival Rates of Primary Ovarian Clear Cell Carcinoma Compared to Ovarian Serous Carcinoma in Korea. | Frontiers in Oncology | 2022 |
| Targeting the DNA Damage Response Pathway as a Novel Therapeutic Strategy in Colorectal Cancer. | Cancers | 2022 |
| Real-World Data on Detection of Germline and Somatic Pathogenic/Likely Pathogenic Variants in and Other Susceptibility Genes in Ovarian Cancer Patients Using Next Generation Sequencing. | Cancers | 2022 |
| CAF-Associated Paracrine Signaling Worsens Outcome and Potentially Contributes to Chemoresistance in Epithelial Ovarian Cancer. | Frontiers in Oncology | 2022 |
| Overview of Immune Checkpoint Inhibitors in Gynecological Cancer Treatment. | Cancers | 2022 |
| Risk factors for and prognosis of carboplatin-related hypersensitivity in patients with epithelial ovarian cancer. | Archives of Gynecology and Obstetrics | 2022 |
| Identifying the Steps Required to Effectively Implement Next-Generation Sequencing in Oncology at a National Level in Europe. | Journal of Personalized Medicine | 2022 |
| Assessment of quality of life among advanced ovarian cancer patients in a tertiary care hospital in India. | Supportive Care in Cancer | 2022 |
| Ultrasonographic Visualization of the Ovaries to Detect Ovarian Cancer According to Age, Menopausal Status and Body Type. | Diagnostics | 2022 |
| Maintenance Treatment of Newly Diagnosed Advanced Ovarian Cancer: Time for a Paradigm Shift? | Cancers | 2021 |
| Options for the Treatment of Mucinous Ovarian Carcinoma | Current Treatment Options in Oncology | 2021 |
| Ovarian cancer (staging) | | |
| Pathologic distribution at the time of interval tumor reductive surgery informs personalized surgery for high-grade ovarian cancer | International Journal of Gynecological Cancer | 2021 |
| Ovarian and Fallopian Tube Cancers | Medical Radiology | 2008 |
| Medical Oncology | | 2008 |
| THE VALUE OF CYTOREDUCTIVE SURGERY FOR ISOLATED LYMPH NODE RECURRENCE OF OVARIAN CANCER | Siberian Journal of Oncology | 2020 |
| PARG inhibition induces replication catastrophe in ovarian cancer cells with down-regulated DNA replication genes | | |
| Distribution of residual disease in the peritoneum following neoadjuvant chemotherapy in advanced epithelial ovarian cancer and its potential therapeutic implications | | |
| Surgical and Survival Outcomes with Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer: A Longitudinal Study in a Tertiary Cancer Center | Journal of SAFOG | 2020 |
| Special Considerations for Peritoneal Washings | | 2020 |
| Breast metastasis from pelvic high-grade serous adenocarcinoma: a report of two cases | Surgical Case Reports | 2020 |
| Molecular Testing in Ovarian Cancer: Recommendations and Treatment Considerations | | 2020 |
| Primary ovarian cancer: possibilities for improving treatment outcomes | Meditsinskiy Sovet | 2019 |
| New Treatment of Advanced Ovarian Cancer: A Literature Review | | 2019 |
| Gynecological Cancer | Principles of Specialty Nursing | 2019 |
| Borderline ovarian tumor in adolescence: report of two cases and review of the literature | International Journal of Radiology & Radiation Therapy | 2018 |
| Strategies for the Management of Epithelial Ovarian Cancer | Comprehensive Gynecology and Obstetrics | 2017 |
| Diagnosis and Management of Nonepithelial Ovarian Cancer | | 2017 |
| Diagnosis and Management of Nonepithelial Ovarian Cancer | | 2016 |
| Advances in the Medical Management of Ovarian Cancer | | 2014 |
| Potential predictors for chemotherapeutic response and prognosis in epithelial ovarian, fallopian tube and primary peritoneal cancer patients treated with platinum-based chemotherapy | Obstetrics and Gynecology Science | 2020 |
| Radiotherapy and Its Intersections with Surgery in the Management of Localized Gynecological Malignancies: A Comprehensive Overview for Clinicians | Journal of Clinical Medicine | 2020 |
| Is HE4 Superior over CA-125 in the Follow-up of Patients with Epithelial Ovarian Cancer? | Current Drug Targets | 2020 |
| RGD-Conjugated Resveratrol HSA Nanoparticles as a Novel Delivery System in Ovarian Cancer Therapy | Drug Design, Development and Therapy | 2020 |
| The prognostic value of Ki67 in ovarian high-grade serous carcinoma: an 11-year cohort study of Chinese patients | Oncotarget | 2017 |
| Impact of neoadjuvant chemotherapy and postoperative adjuvant chemotherapy cycles on survival of patients with advanced-stage ovarian cancer | PLoS ONE | 2017 |
| Muscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced-stage ovarian cancer | Journal of Cachexia, Sarcopenia and Muscle | 2020 |
| as an Emerging Predictive Biomarker in Ovarian Cancer | Diagnostics | 2021 |
| Ovarian cancer: new strategies and emerging targets for the treatment of patients with advanced disease | Cancer Biology and Therapy | 2021 |
| Omental metastasis as a predictive risk factor for unfavorable prognosis in patients with stage III-IV epithelial ovarian cancer | International Journal of Clinical Oncology | 2021 |
| Acute Infusion-Related Reactions: How to Recognize and Intervene When These Reactions Occur in Practice | Clinical Journal of Oncology Nursing | 2021 |
| Bevacizumab Combined with Platinum-Taxane Chemotherapy as First-Line Treatment for Advanced Ovarian Cancer: Results of the NOGGO Non-Interventional Study (OTILIA) in 824 Patients | Cancers | 2021 |
| Association Between Overall Survival and the Tendency for Cancer Programs to Administer Neoadjuvant Chemotherapy for Patients With Advanced Ovarian Cancer | JAMA Oncology | 2021 |
| The complex relationship between infertility and female genital tract cancer: A review | Urologia | 2021 |
| Clinical Outcomes of Patients with High-Grade Ovarian Carcinoma Arising in Endometriosis Compared to Ovarian High-Grade Serous Carcinoma | Indian Journal of Gynecologic Oncology | 2021 |
| The efficacy and safety profile of 2-weekly dosing of bevacizumab-containing chemotherapy for platinum-resistant recurrent ovarian cancer | International Journal of Clinical Oncology | 2021 |
| Molecular predictors of the outcome of paclitaxel plus carboplatin neoadjuvant therapy in high-grade serous ovarian cancer patients | Cancer Chemotherapy and Pharmacology | 2021 |
| Tumor Genotyping and Homologous Recombination Repair Gene Variants in Patients With Epithelial Ovarian Cancer: Is Pathogenic Enough? | Frontiers in Oncology | 2021 |
| Fertility-sparing treatment in advanced-stage serous borderline ovarian tumors. An analysis from the MITO14 study database | Gynecologic Oncology | 2021 |
| Immature teratoma in an adolescent with Proteus syndrome: A novel association | Clinical Case Reports (discontinued) | 2021 |
| Analysis of factors affecting the diagnostic yield of image-guided percutaneous core needle biopsy for peritoneal/omental lesions | Abdominal Radiology | 2021 |
| Radical prostatectomy improves survival in selected metastatic prostate cancer patients: A North American population-based study | International Journal of Urology | 2021 |
| Low-grade serous carcinoma with extensive osseous metaplasia arising from ovarian serous cystadenofibroma | Gynecologic Oncology Reports | 2021 |
| Development of Machine Learning Models to Predict Platinum Sensitivity of High-Grade Serous Ovarian Carcinoma | Cancers | 2021 |
| Fertility preservation in rare ovarian tumors | International Journal of Gynecological Cancer | 2021 |
| Circulating Cell-Free DNA Methylation Profiles in the Early Detection of Ovarian Cancer: A Scoping Review of the Literature | Cancers | 2021 |
| Angiogenesis Inhibitors as Anti-Cancer Therapy Following Renal Transplantation: A Case Report and Review of the Literature | Current Oncology | 2021 |
| Management of recurrent granulosa cell tumor of the ovary: Contemporary literature review and a proposal of hyperthermic intraperitoneal chemotherapy as novel therapeutic option | Journal of Obstetrics and Gynaecology Research | 2021 |
| External beam radiation therapy improves survival in elderly metastatic prostate cancer patients with low PSA | Urologic Oncology: Seminars and Original Investigations | 2021 |
| FDA Approval Summary: Olaparib Monotherapy or in Combination with Bevacizumab for the Maintenance Treatment of Patients with Advanced Ovarian Cancer | Oncologist | 2021 |
| Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook | Cancer Treatment Reviews | 2020 |
| Comparing Paclitaxel-Carboplatin with Paclitaxel-Cisplatin as the Front-Line Chemotherapy for Patients with FIGO IIIC Serous-Type Tubo-Ovarian Cancer | International Journal of Environmental Research and Public Health | 2020 |
| European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis | International Journal of Gynecological Cancer | 2020 |
| An Unusual Ovarian Mass | Indian Journal of Gynecologic Oncology | 2020 |
| Efficacy and safety of 5 mg olanzapine combined with aprepitant, granisetron and dexamethasone to prevent carboplatin-induced nausea and vomiting in patients with gynecologic cancer: A multi-institution phase II study | Gynecologic Oncology | 2020 |
| Effect of Chemotherapy, Laparoscopy, and Cytology on Stage IC Ovarian Clear Cell Carcinoma: A Long-Term, Single-Center Study | International Journal of Environmental Research and Public Health | 2020 |
| Racial and ethnic disparities in the overall survival of women with epithelial ovarian cancer in Florida, 2001-2015 | Cancer Causes and Control | 2020 |
| Overcoming cisplatin resistance by targeting the MTDH-PTEN interaction in ovarian cancer with sera derived from rats exposed to Guizhi Fuling wan extract | BMC Complementary Medicine and Therapies | 2020 |
| PARP Inhibitors in Gynecologic Cancers: What Is the Next Big Development? | Current Oncology Reports | 2020 |
| Immunotherapy For Ovarian Cancer: Recent Advances And Combination Therapeutic Approaches | OncoTargets and Therapy | 2020 |
| Mitomycin C plus cisplatin for systemic treatment of recurrent BRCA1-associated ovarian cancer | Investigational New Drugs | 2020 |
| Race and Ethnicity Influence Survival Outcomes in Women of Caribbean Nativity With Epithelial Ovarian Cancer | Frontiers in Oncology | 2020 |
| Management of Adverse Events During Rucaparib Treatment for Relapsed Ovarian Cancer: A Review of Published Studies and Practical Guidance | Targeted Oncology | 2020 |
| Ibrutinib in Gynecological Malignancies and Breast Cancer: A Systematic Review | International Journal of Molecular Sciences | 2020 |
| Left Supraclavicular Lymph Node Metastasis from Ovarian Cancer Associated with Papillary Thyroid Microcarcinoma, a Confusing Pathology-Essential Role of Functional Imaging | Diagnostics | 2020 |
| An overview and update of hyperthermic intraperitoneal chemotherapy in ovarian cancer | Expert Opinion on Pharmacotherapy | 2020 |
| Granulosa cell tumor resection with subsequent onset of rheumatoid arthritis | Gynecologic Oncology Reports | 2020 |
| A Critical Appraisal and Recommendations for Cost-Effectiveness Studies of Poly(ADP-Ribose) Polymerase Inhibitors in Advanced Ovarian Cancer | Pharmacoeconomics | 2020 |
| Somatic Testing and Germline Genetic Status: Implications for Cancer Treatment Decisions and Genetic Counseling | Current Genetic Medicine Reports | 2020 |
| Poly (ADP-ribose) polymerase inhibitor exposure reduces ovarian reserve followed by dysfunction in granulosa cells | Scientific Reports | 2020 |
| Therapeutic options following second-line platinum-based chemotherapy in patients with recurrent ovarian cancer: Comparison of active surveillance and maintenance treatment | Cancer Treatment Reviews | 2020 |
| First-Line Treatment with Olaparib for Early Stage BRCA-Positive Ovarian Cancer: May It Be Possible? Hypothesis Potentially Generating a Line of Research | Cancer Management and Research | 2020 |
| Effect of delayed palliative chemotherapy on survival of patients with recurrent ovarian cancer | PLoS ONE | 2020 |
| The role of CA-125, GLS and FASN in predicting cytoreduction for epithelial ovarian cancers | BMC Research Notes | 2020 |
| Effects of initiating physician-performed germline testing in safety net clinic patients with epithelial overian cancer | Gynecologic Oncology Reports | 2020 |
| Factors associated with high-cost hospitalizations in elderly ovarian cancer patients | Gynecologic Oncology | 2020 |
| The role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis: a systematic review including evidence from Japan | Surgery Today | 2021 |
| Utilization and Treatment Patterns of Cytoreduction Surgery and Intraperitoneal Chemotherapy in the United States | Annals of Surgical Oncology | 2020 |
| State-of-the-art strategies for targeting the DNA damage response in cancer | Nature Reviews Clinical Oncology | 2019 |
| The INTERNATIONAL MISSION study: minimally invasive surgery in ovarian neoplasms after neoadjuvant chemotherapy | International Journal of Gynecological Cancer | 2019 |
| Epigenetic therapy for ovarian cancer: promise and progress | Clinical Epigenetics | 2019 |
| β-hCG promotes epithelial ovarian cancer metastasis through ERK/MMP2 signaling pathway | Cell Cycle | 2019 |
| Intraperitoneal Chemotherapy: The Lived Experiences of Taiwanese Patients With Ovarian Cancer | Clinical Journal of Oncology Nursing | 2019 |
| Minimally invasive interval cytoreductive surgery: it's time for a randomized trial | International Journal of Gynecological Cancer | 2019 |
| Are omentectomy and lymphadenectomy necessary in patients with apparently early-stage malignant ovarian germ cell tumors? | International Journal of Gynecological Cancer | 2019 |
| Utero-ovarian preservation and overall survival of young women with early-stage borderline ovarian tumors | Archives of Gynecology and Obstetrics | 2019 |
| Thyroid Cancer Benefits the Prognosis of Ovarian Cancer: A SEER-Based Study | Advances in Therapy | 2019 |
| Ovarian Cancer: An Integrated Review | Seminars in Oncology Nursing | 2019 |
| Identifying disparities in germline and somatic testing for ovarian cancer | Gynecologic Oncology | 2019 |
| Staging Laparotomy in Early Ovarian Cancer | Comprehensive Gynecology and Obstetrics | 2019 |
| Early-stage mucinous carcinoma (infiltrative type) of the ovary and fertility preservation | International Journal of Gynecological Cancer | 2019 |
| A phase II randomized controlled study of pegylated liposomal doxorubicin and carboplatin vs. gemcitabine and carboplatin for platinum-sensitive recurrent ovarian cancer (GOTIC003/intergroup study) | International Journal of Clinical Oncology | 2019 |
| Gynecologic Cancer Survivorship | Obstetrics and Gynecology Clinics of North America | 2019 |
| Ovarian Cancer: Clinical Trial Breakthroughs and Impact on Management | Obstetrics and Gynecology Clinics of North America | 2019 |
| Efficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer: Phase 1b Results From the JAVELIN Solid Tumor Trial | JAMA Oncology | 2019 |
| The prognosis of stage IA synchronous endometrial endometrioid and ovarian carcinomas | Archives of Gynecology and Obstetrics | 2019 |
| Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer: An Institutional Experience | Indian Journal of Gynecologic Oncology | 2019 |
| Real-World Impact of Survival by Period of Diagnosis in Epithelial Ovarian Cancer Between 1990 and 2014 | Frontiers in Oncology | 2019 |
| Maintenance therapy for recurrent epithelial ovarian cancer: current therapies and future perspectives - a review | Journal of Ovarian Research | 2019 |
| Therapeutic Challenges for Cisplatin-Resistant Ovarian Germ Cell Tumors | Cancers | 2019 |
| Germ Cell Tumors of the Ovary | | 2019 |
| Poly-ADP-ribose polymerase inhibitor use in ovarian cancer: expanding indications and novel combination strategies | International Journal of Gynecological Cancer | 2019 |
| Erhaltungstherapie mit Olaparib führt zu signifikant verlängertem PFS | InFo Hämatologie + Onkologie | 2019 |
| Minimally invasive interval cytoreductive surgery in ovarian cancer: systematic review and meta-analysis | Journal of Robotic Surgery | 2019 |
| Maintenance treatment of recurrent ovarian cancer: Is it ready for prime time? | Cancer Treatment Reviews | 2018 |
| Ovarian Cancer | | 2018 |
| The impact of pharmacokinetic gene profiles across human cancers | BMC Cancer | 2018 |
| Gynecologic Cancer | | 2018 |
| High-Grade Serous Ovarian Cancer: Use of Machine Learning to Predict Abdominopelvic Recurrence on CT on the Basis of Serial Cancer Antigen 125 Levels | Journal of the American College of Radiology | 2018 |
| Clinical application of photodynamic diagnosis and photodynamic therapy for gynecologic malignant diseases: A review | Photodiagnosis and Photodynamic Therapy | 2018 |
| Pretreatment neutrophil-to-lymphocyte ratio and its dynamic change during neoadjuvant chemotherapy as poor prognostic factors in advanced ovarian cancer | Obstetrics and Gynecology Science | 2018 |
| Using PARP Inhibitors in the Treatment of Patients With Ovarian Cancer | Current Treatment Options in Oncology | 2018 |
| Germ Cell Tumors of the Ovary | | 2018 |
| The Effect of Histological Subtypes on Outcomes of Stage IV Epithelial Ovarian Cancer | Frontiers in Oncology | 2018 |
| How safe is rucaparib in ovarian cancer? | Expert Opinion on Drug Safety | 2018 |
| Cancer Genetic Counseling and Testing: Perspectives of Epithelial Ovarian Cancer Patients and Gynecologic Oncology Healthcare Providers | Journal of Genetic Counseling | 2018 |
| Impact of lympho-vascular space invasion on tumor characteristics and survival outcome of women with low-grade serous ovarian carcinoma | Journal of Surgical Oncology | 2018 |
| Comparative efficacy evaluation of catheter intraperitoneal chemotherapy, normothermic and hyperthermic chemoperfusion in a rat model of ascitic ovarian cancer | International Journal of Hyperthermia | 2018 |
| Fertility sparing surgery in epithelial ovarian cancer in Italy: perceptions, practice, and main issues | Gynecological Endocrinology | 2018 |
| ACR Appropriateness Criteria Staging and Follow-Up of Ovarian Cancer | Journal of the American College of Radiology | 2018 |
| Clinical study of hereditary ovarian cancer syndrome in Shandong province, East China | International Journal of Gynecology and Obstetrics | 2018 |
| The Role of Computed Tomography and Magnetic Resonance Imaging in Gynecologic Oncology | PET Clinics | 2018 |
